Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hwang

Showing results (341-350 of 346) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 346 results.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Pageof 35

Showing results (341-350 of 346) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 346 results.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Pageof 35